Eliciting Host Immunity Selectively against Cancer Cells Treated with Silica-Phthalocyanine-Based Near Infrared Photoimmunotherapy

Hisataka Kobayashi

doi:10.1364/CLEO_AT.2017.ATu3A.4

Conference on Lasers and Electro-Optics
OSA Technical Digest (online) (Optica Publishing Group, 2017),
paper ATu3A.4
•https://doi.org/10.1364/CLEO_AT.2017.ATu3A.4

Eliciting Host Immunity Selectively against Cancer Cells Treated with Silica-Phthalocyanine-Based Near Infrared Photoimmunotherapy

Hisataka Kobayashi

CLEO: Applications and Technology 2017

San Jose, California United States
14–19 May 2017
ISBN: 978-1-943580-27-9

From the session
Photobiomodulation Therapeutics (ATu3A)

Not Accessible

Your library or personal account may give you access

Get PDF
Email
Share
Get Citation
Copy Citation Text
H. Kobayashi, "Eliciting Host Immunity Selectively against Cancer Cells Treated with Silica-Phthalocyanine-Based Near Infrared Photoimmunotherapy," in Conference on Lasers and Electro-Optics, OSA Technical Digest (online) (Optica Publishing Group, 2017), paper ATu3A.4.

Export Citation
- BibTex
- Endnote (RIS)
- HTML
- Plain Text
Citation alert
Save article

Abstract

Near infrared photoimmunotherapy (NIR-PIT) is a new type of molecularly-targeted cancer photo-therapy based on antibody-photosensitizer conjugates. By crashing cancer or immuno-suppressor cells, NIR-PIT efficiently activates host immunity against NIR-PIT treated cancer cells growing in patients.

PDF Article

More Like This

Near Infrared Photoimmunotherapy for Cancer

Hisataka Kobayashi
AM1I.2 CLEO: Applications and Technology (CLEO:A&T) 2019

Near Infrared Photoimmunotherapy of Cancer

Hisataka Kobayashi
AW2T.2 CLEO: Applications and Technology (CLEO:A&T) 2021

Near infrared photo-immunotherapy: A newly developed, target cell-specific cancer theranostic technology

Hisataka Kobayashi
OM2D.2 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2015

Previous Article Next Article